Cambridge Investment Research Advisors’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $184K | Sell |
20,003
-228,136
| -92% | -$2.1M | ﹤0.01% | 3365 |
|
|
2025
Q1 | $2.13M | Buy |
248,139
+164,792
| +198% | +$1.41M | 0.01% | 1295 |
|
|
2024
Q4 | $895K | Buy |
83,347
+63,074
| +311% | +$677K | ﹤0.01% | 1963 |
|
|
2024
Q3 | $115K | Buy |
20,273
+4,000
| +25% | +$22.7K | ﹤0.01% | 3247 |
|
|
2024
Q2 | $69K | Sell |
16,273
-100
| -0.6% | -$424 | ﹤0.01% | 3196 |
|
|
2024
Q1 | $83K | Buy |
16,373
+498
| +3% | +$2.53K | ﹤0.01% | 3166 |
|
|
2023
Q4 | $148K | Sell |
15,875
-400
| -2% | -$3.73K | ﹤0.01% | 2972 |
|
|
2023
Q3 | $107K | Buy |
+16,275
| New | +$107K | ﹤0.01% | 2951 |
|